glp 1 agonist overdose Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study GLP-1 receptor agonists show promise
Description
More than one in ten people in Saudi Arabia is living with diabetes, and the prevalence of the disease will almost double by 2045, according to a report by the International Diabetes Federation
However, weight reduction appears to be more substantial when the GLP1-RA is added first
Tirzepatide showed the greatest reduction in likelihood, with a 60% reduction, as seen in Figure 2
While preliminary studies and observational signals suggest potential thyroidal effects, no RCTs have evaluated progression of Hashimoto thyroiditis or Graves disease under GLP-1RA therapy [32,58]
Immunology 172 (3), 451468
